Novavax Inc. closed 61.59% short of its 52-week high of $17.81, which the company achieved on July 26th.

F indings from a Phase I trial initiated by Dana-Farber Cancer Institute have demonstrated that the NeoVax personalised cancer vaccine’s updated formula and delivery, NeoVax MI ,is not only feasible ...

Supplements are part of the daily routine for over half of adults in the United States. However, they aren't regulated in ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.

Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...